|
Q2 FY2016
As of Apr 30, 2016
|
Q1 FY2016
As of Jan 31, 2016
|
Q4 FY2015
As of Oct 31, 2015
|
Q3 FY2015
As of Jul 31, 2015
|
Q2 FY2015
As of Apr 30, 2015
|
Q1 FY2015
As of Jan 31, 2015
|
Q3 FY2014
As of Jul 31, 2014
|
Q2 FY2014
As of Apr 30, 2014
|
Q1 FY2014
As of Jan 31, 2014
|
Q4 FY2013
As of Oct 31, 2013
|
Q3 FY2013
As of Jul 31, 2013
|
Q2 FY2013
As of Apr 30, 2013
|
Q1 FY2013
As of Jan 31, 2013
|
Q4 FY2012
As of Oct 31, 2012
|
Q3 FY2012
As of Jul 31, 2012
|
Q2 FY2012
As of Apr 30, 2012
|
Q1 FY2012
As of Jan 31, 2012
|
Q4 FY2011
As of Oct 31, 2011
|
Q3 FY2011
As of Jul 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDER'S DEFICIT | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accrued Expenses | |||||||||||||||||||
| Due to Parent | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Stockholder's Deficit | |||||||||||||||||||
| Preferred Stock: $.001 Par; 20,000,000 Shares Authorized, -0- Issued and Outstanding | |||||||||||||||||||
| Common Stock: $.001 Par; 100,000,000 Shares Authorized; 5,000,000 Issued and Outstanding at April 30, 2016 and October 31, 2015 | |||||||||||||||||||
| Additional Paid-In-Capital | |||||||||||||||||||
| Deficit Accumulated During Development Stage | |||||||||||||||||||
| Deficit | |||||||||||||||||||
| Accumulated Deficit | |||||||||||||||||||
| Total Stockholder's Deficit | |||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | |||||||||||||||||||
Loading...
